Phase I trial investigating the safety and immunogenicity of Medicago's rabies vaccine.
Phase of Trial: Phase I
Latest Information Update: 20 Jan 2012
At a glance
- Drugs Rabies vaccine (Primary)
- Indications Rabies
- Focus Adverse reactions
- 20 Jan 2012 Medicago expects to initiate Good Manufacturing Practice (GMP) process development and a Good Laboratory Practice (GLP) toxicology study in 2012; following this, the company will initiate this phase I clinical trial.
- 20 Jan 2012 New trial record